Pathstone Family Office’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$381K Buy
20,550
+6,957
+51% +$152K ﹤0.01% 1178
2023
Q2
$296K Buy
+13,593
New +$246K ﹤0.01% 967
2023
Q1
Sell
-39,802
Closed -$410K 1404
2022
Q4
$410K Buy
+39,802
New +$567K ﹤0.01% 1181
2022
Q2
Sell
-4,860
Closed -$200K 1113
2022
Q1
$200K Buy
+4,860
New +$175K ﹤0.01% 896

Other funds holding NEOG

Pathstone Family Office's NEOG Position: Q3 2023 in Review

Pathstone Family Office increased its Neogen (NEOG) stake by 51% in Q3 2023, buying an estimated $152K and bringing the position to 20,550 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #1178.

Pathstone Family Office first reported a position in NEOG in Q1 2022 and has held it in 4 quarters since. The position peaked at $410K in Q4 2022. 366 funds tracked by Wall St. Rank hold NEOG as of Q3 2023.

  • Pathstone Family Office held 20,550 shares of Neogen worth $381K as of Q3 2023.
  • Pathstone Family Office bought 6,957 Neogen shares in Q3 2023, an estimated $152K.
  • Neogen made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1178 holding.
  • Pathstone Family Office first reported a position in Neogen in Q1 2022 and has held it in 4 quarters since.
  • Pathstone Family Office's Neogen position peaked at $410K in Q4 2022.
  • 366 funds tracked by Wall St. Rank held Neogen as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.